TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS AND THE BREAK OF B-CELL TOLERANCE TO AUTOANTIGENS

被引：0
|
作者：
de Moel, E. G. [1 ]
Rozeman, L. [2 ]
Grummels, A. [3 ]
Verdegaal, E. M. E. [4 ]
Bakker, J. A. [3 ]
Kapiteijn, E. H. [4 ]
Huizinga, T. W. J. [1 ]
Haanen, J. B. [2 ]
Toes, R. E. M. [1 ]
van der Woude, D. [1 ]
机构：
[1] Leiden Univ, Rheumatol, Med Ctr, Leiden, Netherlands
[2] Netherlands Canc Inst, Med Oncol & Immunol, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Clin Chem & Lab Med, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Med Oncol, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0024
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [21] B-Cell Factor Possible Key to Hemophilia Immune Tolerance
    不详
    US PHARMACIST, 2021, 46 (05) : 39 - 40
  • [22] B-cell tolerance
    Ferry, H
    Leung, JCH
    Lewis, G
    Nijnik, A
    Silver, K
    Lambe, T
    Cornall, RJ
    TRANSPLANTATION, 2006, 81 (03) : 308 - 315
  • [23] B-CELL TOLERANCE
    GOODNOW, CC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (06) : 703 - 710
  • [24] B-Cell Epitopes of Intracellular Autoantigens: Myth and Reality
    N. M. Moutsopoulos
    J. G. Routsias
    P. G. Vlachoyiannopoulos
    A. G. Tzioufas
    H. M. Moutsopoulos
    Molecular Medicine, 2000, 6 : 141 - 151
  • [25] B-cell epitopes of intracellular autoantigens: Myth and reality
    Moutsopoulos, NM
    Routsias, JG
    Vlachoyiannopoulos, PG
    Tzioufas, AG
    Moutsopoulos, HM
    MOLECULAR MEDICINE, 2000, 6 (03) : 141 - 151
  • [26] B-CELL EPITOPES OF SCLERODERMA-SPECIFIC AUTOANTIGENS
    VERHEIJEN, R
    MOLECULAR BIOLOGY REPORTS, 1992, 16 (03) : 183 - 189
  • [27] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
  • [28] Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
    Stern, Peter L.
    Dalianis, Tina
    VIRUSES-BASEL, 2021, 13 (07):
  • [29] Immune responses against immunogenic neoantigens enable to break the resistance to immune checkpoint inhibitors
    Sugiyama, Daisuke
    Muramatsu, Tomoaki
    Noguchi, Takuro
    Kato, Shinichiro
    Hinohara, Kunihiko
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2022, 113
  • [30] B-Cell Receptor Signaling Inhibitors for Treatment of Autoimmune Inflammatory Diseases and B-Cell Malignancies
    Puri, Kamal D.
    Di Paolo, Julie A.
    Gold, Michael R.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2013, 32 (04) : 397 - 427
12345